All Stories

  1. Cancer care in wartime Ukraine: disruption, resilience and recovery
  2. Robotic versus open cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a propensity score-matched study
  3. Education in Adversity: Enhancing Surgical Training Through the “Principles of Surgery” Course in Wartime Ukraine
  4. Controlling Perfusion Temperature Relates to Better Outcomes after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
  5. Enhancing Colonoscopy Quality: Evaluating Adherence to Performance Measures in Ukraine
  6. Impact of Representation on Gender Stereotypes and Discrimination for Women Surgeons in Ukraine
  7. Consensus guideline for the management of gastric cancer with synchronous peritoneal metastases
  8. Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases
  9. Utility of Left Lateral Liver Lobectomy in Removing Retrohepatic Lesions During Cytoreductive Surgery for Low-Grade Mucinous Carcinoma Peritonei
  10. Adoption of the Enhanced Recovery After Surgery Practices for Colorectal Procedures: A Nationwide Assessment in Ukraine
  11. Prognostic Value of Preoperative Serum C-reactive Protein Level for Survival in Mucinous Appendix Cancer Treated with Complete CRS/HIPEC
  12. Enhanced Recovery After Surgery Protocol Compliance and Early Outcomes for Elective Colorectal Procedures by Race/Ethnicity and Socioeconomic Status
  13. ASO Visual Abstract: Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): Cancer Survivors’ Perspective Through in-Depth Interviews
  14. Building an Effective International Medical Evacuation Program for Ukrainian Patients With Cancer Amid Prolonged Military Conflict
  15. Impact of Various Treatment Modalities on Long-Term Quality of Life in Cervical Cancer Survivors
  16. Impact of Multi-Institutional Enhanced Recovery after Surgery Protocol Implementation on Elective Colorectal Surgery Outcomes
  17. Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): Cancer Survivors’ Perspective Through In-Depth Interviews
  18. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) vs. Postoperative Intraperitoneal (IP) Chemotherapy - Impact on Health-Related Quality of Life in Primary Ovarian Cancer Patients after Cytoreductive Surgery
  19. Risk Factors of a Positive Resection Margin in Locoregional Appendix Cancer and Its Impact on Survival: The National Cancer Database Analysis
  20. ASO Author Reflections: Shaping Paraganglioma Management from Operating Rooms to Genetic Labs
  21. Tailoring postoperative management through sentinel lymph node biopsy in low- and intermediate-risk endometrial cancer – the SENTRY clinical trial
  22. Paraaortic Extra-Adrenal Paraganglioma: Challenging Robotic Resection
  23. Building an Efficient Peritoneal Surface Malignancies Program Despite the Lower-Middle–Income Barriers: Ukraine Experience
  24. ASO Visual Abstract: Sufficient Regional Lymph Node Examination for Staging Adenocarcinoma of the Appendix
  25. Collaborative expertise of gynecological and surgical oncologists in managing advanced epithelial ovarian cancer
  26. Sufficient Regional Lymph Node Examination for Staging Adenocarcinoma of the Appendix
  27. ASO Visual Abstract: Patterns of Recurrence in Appendix Cancer After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
  28. Patterns of Recurrence in Appendix Cancer After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
  29. ASO Author Reflections: Let’s Redouble Efforts to Stop Peritoneal Recurrence in All Types of Appendix Cancer
  30. Risk Factors for COVID-19 Adverse Outcomes in ICU Settings of Various Types Repurposed Hospitals
  31. Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal dissemination from ovarian carcinosarcoma
  32. ASO Visual Abstract: Safety of Nephrectomy Performed During CRS/HIPEC—A Propensity Score-Matched Study
  33. ASO Author Reflections: Should I Stay or Should I Go? Nephrectomy for Complete CRS/HIPEC
  34. Safety of Nephrectomy Performed During CRS/HIPEC: A Propensity Score-Matched Study
  35. Adjuvant chemotherapy for high-grade appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
  36. ASO Visual Abstract: Systemic Chemotherapy in High-Grade Mucinous Appendiceal Cancer with Peritoneal Spread after Unsuccessful Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)
  37. Systemic Chemotherapy for High-Grade Mucinous Appendiceal Cancer with Peritoneal Spread After Unsuccessful CRS/HIPEC
  38. Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix
  39. ASO Visual Abstract: Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix
  40. Aorta Tetrafurcation
  41. Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy with and without Diaphragmatic Resection in Patients with Peritoneal Metastases
  42. ASO Author Reflections: What to Expect After You Resect Diaphragm During CRS/HIPEC
  43. ASO Visual Abstract: Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy With and Without Diaphragmatic Resection in Patients with Peritoneal Metastases
  44. Delayed genital necrosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with Mitomycin-C
  45. ASO Author Reflections: Pleural Spread of Peritoneal Malignancies: When Heated Chemoperfusion Can Save the Day
  46. Target Groups for a Short Dexamethasone Course among Critically Ill COVID-19 Patients
  47. Cytoreductive Surgery with Hyperthermic Intrathoracic Chemotherapy for Patients with Intrapleural Dissemination of Peritoneal Surface Malignancies
  48. ASO Visual Abstract: Cytoreductive Surgery with Hyperthermic Intrathoracic Chemotherapy for Patients With Intrapleural Dissemination of Peritoneal Surface Malignancies
  49. Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25‐year experience
  50. Management of Low-Grade Appendiceal Mucinous Neoplasm with Extensive Peritoneal Spread Diagnosed during Pregnancy: Two Case Reports and Literature Review
  51. Diffuse Ectopic Deciduosis Imitating Peritoneal Carcinomatosis with Acute Abdomen Presentation: A Case Report and Literature Review
  52. Pelvic Anastomosis Without Protective Ileostomy is Safe in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
  53. ASO Author Reflections: Not All Low-Grade Appendiceal Mucinous Neoplasm Mucin is Created Equal
  54. Impact of Mucin Cellularity and Distribution on Survival in Newly Diagnosed Patients with Low-Grade Appendiceal Mucinous Neoplasm Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
  55. A Rare Case of Metastatic Heterogeneous Poorly Differentiated Neuroendocrine Carcinoma of Ileum: A Case Report and Literature Review
  56. Soft-Tissue Myoepithelioma of the Retroperitoneal Space Mimicking a Pancreatic Tumor: A Case Report and Literature Review